VAV3 and neoplasm: Our pooled analysis of 19 studies indicated that VAV3 may have tumor-suppressive properties, as it is downregulated in kidney cancers, and that higher VAV3 mRNA expression levels were associated with better survival outcomes in patients with RCC.